These production facilities are all subject, where they are, to the usual kinds of regulatory controls, as would be a facility were we to build it here. If we built it here, there's no guarantee that it would be any better than one built anywhere else. That's just a practical reality.
The point is that for the clinical trials, for ethics reviews, for all of these purposes, they have to meet those standards. It's in the scientific world; you're not going to be able to cover 99.9999% of every issue or every question. The point is that the capacity is there and it's with reputable organizations, and the feeling is that there is sufficient capacity now to address what we need going forward.